Trend Analysis for the Choice and Cost of Lung Cancer Treatment in South Korea, 2003-2013
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose Our study aimed to report the annual changes in lung cancer statistics and analyze trends in sociodemographic, medical, and financial factors from 2003 to 2013 in the national database from the Korean National Health Insurance (KNHI). Materials and Methods Among 7,489 patients with code C34 in KNHI database, only lung cancer patients newly diagnosed after 2003 were included in the study population, for a total of 4,582 patients. Descriptive statistics were used to characterize treatment patterns and medical costs according to sociodemographic factors. Results Approximately 70% of subjects were male, and the mean age was 67 years. Around 46% of patients were over 70 years old, and 12% were over 80 years old. The medical costs were highest for patients younger than 60 and lowest for those over 80 years old. Surgery was more common in younger patients, while “no treatment” increased greatly with age. In trend analysis, the proportions of aging (p for trend < 0.001), female (p for trend=0.003), metropolitan/urban (p for trend=0.041), and lowest or highest-income patients (p for trend=0.004) increased over time, along with the prevalence of surgery as the primary treatment (p for trend < 0.001). There was also a trend with regard to change in medical costs (p for trend < 0.001), in that those of surgery and radiotherapy increased. Conclusion Surgery as a curative treatment has increased over the past decade. However, the elderly, suburban/rural residents, and low-income patients were more likely to be untreated. Therefore, active measures are required for these increasingly vulnerable groups.
Abstract
Purpose Our study aimed to report the annual changes in lung cancer statistics and analyze trends in sociodemographic, medical, and financial factors from 2003 to 2013 in the national database from the Korean National Health Insurance (KNHI). Materials and Methods Among 7,489 patients with code C34 in KNHI database, only lung cancer patients newly diagnosed after 2003 were included in the study population, for a total of 4,582 patients. Descriptive statistics were used to characterize treatment patterns and medical costs according to sociodemographic factors. Results Approximately 70% of subjects were male, and the mean age was 67 years. Around 46% of patients were over 70 years old, and 12% were over 80 years old. The medical costs were highest for patients younger than 60 and lowest for those over 80 years old. Surgery was more common in younger patients, while “no treatment” increased greatly with age. In trend analysis, the proportions of aging (p for trend < 0.001), female (p for trend=0.003), metropolitan/urban (p for trend=0.041), and lowest or highest-income patients (p for trend=0.004) increased over time, along with the prevalence of surgery as the primary treatment (p for trend < 0.001). There was also a trend with regard to change in medical costs (p for trend < 0.001), in that those of surgery and radiotherapy increased. Conclusion Surgery as a curative treatment has increased over the past decade. However, the elderly, suburban/rural residents, and low-income patients were more likely to be untreated. Therefore, active measures are required for these increasingly vulnerable groups.
참고문헌 (24)
- 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2012", Cancer Research and Treatment, 47(2), pp.127~141 (2015), 대한암학회[DOI]
- Torre LA, "Global cancer statistics, 2012", CA Cancer J Clin, 65, pp.87~108 (2015)[DOI]
- Miller DL, "Community-based multidisciplinary computed tomography screening program improves lung cancer survival", Ann Thorac Surg, 101, pp.1864~1869 (2016)[DOI]
- Patz EF Jr, "Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial", Lancet Oncol, 17, pp.590~599 (2016)[DOI]
- Islami F, "Global trends of lung cancer mortality and smoking prevalence", Transl Lung Cancer Res, 4, pp.327~338 (2015)
- Min Suk Choi, "Analysis of 1,067 Cases of Video-Assisted Thoracic Surgery Lobectomy", Journal of Chest Surgery, 44(2), pp.169~177 (2011), 대한심장혈관흉부외과학회
- Ikeda N, "Recent advances in video-assisted thoracoscopic surgery for lung cancer", Asian J Endosc Surg, 6, pp.9~13 (2013)[DOI]
- Salama JK, "New radiotherapy and chemoradiotherapy approaches for non-small-cell lung cancer", J Clin Oncol, 31, pp.1029~1038 (2013)[DOI]
- Chang JY, "Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials", Lancet Oncol, 16, pp.630~637 (2015)[DOI]
- Cheng TY, "The international epidemiology of lung cancer: latest trends, disparities, and tumor characteristics", J Thorac Oncol, 11, pp.1653~1671 (2016)[DOI]
- Bray F, "Global cancer transitions according to the Human Development Index (2008-2030): a population-based study", Lancet Oncol, 13, pp.790~801 (2012)[DOI]
- 정규원, "Prediction of Cancer Incidence and Mortality in Korea, 2016", Cancer Research and Treatment, 48(2), pp.451~457 (2016), 대한암학회
- Lim D, "Trends in major cancer mortality in Korea, 1983-2012, with a joinpoint analysis", Cancer Epidemiol, 39, pp.939~946 (2015)[DOI]
- 권석현, "청소년의 평생 흡연 및 현재 흡연 영향요인: 제10차(2014년) 청소년건강행태온라인조사 통계를 이용하여", Journal of Korean Academy of Nursing, 46(4), pp.552~561 (2016), 한국간호과학회
- Eckel SP, "Air pollution affects lung cancer survival", Thorax, 71, pp.891~898 (2016)[DOI]
- Chen G, "Traffic-related air pollution and lung cancer: a meta-analysis", Thorac Cancer, 6, pp.307~318 (2015)[DOI]
- Wang A, "Physical activity and sedentary behavior in relation to lung cancer incidence and mortality in older women: The Women's Health Initiative", Int J Cancer, 139, pp.2178~2192 (2016)[DOI]
- Koshy M, "Improved survival associated with neoadjuvant chemoradiation in patients with clinical stage IIIA(N2) non-small-cell lung cancer", J Thorac Oncol, 8, pp.915~922 (2013)[DOI]
- Kim HK, "Outcomes of neoadjuvant concurrent chemoradiotherapy followed by surgery for non-small-cell lung cancer with N2 disease", Lung Cancer, 96, pp.56~62 (2016)[DOI]
- Herskovic A, "Addition of surgery after radiation significantly improves survival in stage IIIB non-small cell lung cancer: a populationbased analysis", World J Surg, 41, pp.758~762 (2017)[DOI]
- Janet-Vendroux A, "Which is the role of pneumonectomy in the era of parenchymal-sparing procedures? Early", long-term survival and functional results of a single-center experience, 2015, pp.193, 965~973
- Park BJ, "Robotic assistance for videoassisted thoracic surgical lobectomy: technique and initial results", J Thorac Cardiovasc Surg, 131, pp.54~59 (2006)[DOI]
- Hirsch FR, "New and emerging targeted treatments in advanced non-small-cell lung cancer", Lancet, 388, pp.1012~1024 (2016)[DOI]
- 신애선, "Lung Cancer Epidemiology in Korea", Cancer Research and Treatment, 49(3), pp.616~626 (2017), 대한암학회